Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Universal Prevention of Depression and Anxiety in the General Population Through a Personalized Intervention Based on Risk Algorithms, ICTs, and Decision Support Systems: Randomized Controlled Trial. The "PredictPlusPrevent" Study

NCT06351800 is registered in ClinicalTrials.gov with The Mediterranean Institute for the Advance of Biotechnology and Health Research as lead sponsor.

NCT NCT06351800
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06351800 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Universal Prevention of Depression and Anxiety in the General Population Through a Personalized Intervention Based on Risk Algorithms, ICTs, and Decision Support Systems: Randomized Controlled Trial. The "PredictPlusPrevent" Study
Lead sponsor
The Mediterranean Institute for the Advance of Biotechnology and Health Research
Phase
Not applicable
Overall status
Not yet recruiting
Start date
February 15, 2026
Completion date
March 7, 2028
Enrollment
9,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety disorders, depression